These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide. Boffa GM; Zaninotto M; Sartor R; Mion M; Berton A; Pasqualetto C; Razzolini R; Plebani M J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):758-64. PubMed ID: 19553828 [TBL] [Abstract][Full Text] [Related]
5. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients. Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505 [TBL] [Abstract][Full Text] [Related]
6. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508 [TBL] [Abstract][Full Text] [Related]
7. Plasma cardiac natriuretic peptide levels in screening for cardiac disease. Nicholls MG; Obineche EN; Frampton CM; Richards AM Am J Med; 2004 Apr; 116(8):561-3. PubMed ID: 15063820 [No Abstract] [Full Text] [Related]
8. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure. Boffa GM; Zaninotto M; Nalli C; Forni M; Tiso E; Razzolini R; Plebani M Ital Heart J; 2004 Jan; 5(1):48-52. PubMed ID: 15080581 [TBL] [Abstract][Full Text] [Related]
9. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235 [TBL] [Abstract][Full Text] [Related]
10. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators. Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory mediators in Chinese patients with congestive heart failure. Wang Y; Zhou Y; Meng L; Lu X; Ou N; Li X J Clin Pharmacol; 2009 May; 49(5):591-9. PubMed ID: 19398605 [TBL] [Abstract][Full Text] [Related]
12. [Monitoring heart failure with brain natriuretic peptide]. Sela B Harefuah; 2003 Jan; 142(1):25-31, 78. PubMed ID: 12647486 [TBL] [Abstract][Full Text] [Related]
13. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure. Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553 [TBL] [Abstract][Full Text] [Related]
15. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure]. Dong H; Chen DQ; Wang Y; Li M Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908 [TBL] [Abstract][Full Text] [Related]
16. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745 [TBL] [Abstract][Full Text] [Related]
17. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
18. The use of B-type natriuretic peptide in paediatric patients: a review of literature. Favilli S; Frenos S; Lasagni D; Frenos F; Pollini I; Bernini G; Aricò M; Bini RM J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):298-302. PubMed ID: 19430339 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine. Bertinchant JP; Combes N; Polge A; Fabbro-Peray P; Raczka F; Beck L; Cade S; Ledermann B Clin Chim Acta; 2005 Feb; 352(1-2):143-53. PubMed ID: 15653109 [TBL] [Abstract][Full Text] [Related]
20. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation. Wozakowska-Kapłon B; Opolski G Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]